Source: Annual Congress 2011 - Animal models of airway inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Starkhammar, S. Georen-Kumlien, S. E. Dahlén, M. Adner, L. O. Cardell (Stockholm, Sweden). Poly I:C treatment causes fatal AHR in sensitized mice. Eur Respir J 2011; 38: Suppl. 55, 966

Member's Comments

No comment yet.

Related content which might interest you: The relationship between PBMC secretion of IFN-alpha following stimulation by Poly (I:C) and clinical indices in COPD Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Increased expression of microRNA-146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 T-cell mediated inflammation is is not required for sustained AHR that persists in mice following chronic allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 482s Year: 2003 Effects of PKR inhibitor on poly (I:C)-induced exacerbation of severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Intratracheal challenged mice asthma model: can pure low airways inflammation influence the nose? Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Chronic LPS instillation model in mice: a useful model for emphysema studies? Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma Year: 2005 A robust translational model of acute exacerbations in the tobacco-smoke and poly IC treated mouse Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 In utero supplementation with methyl donors enhances allergic airway disease in mice Source: Annual Congress 2009 - Early life origins of asthma and atopy: is epigenetics the key? Year: 2009 Effects of thioredoxin-1 on accelerated emphysema progression in cigarette smoke-exposed mice challenged with polyinosine-polycytidylic acid Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Poly (IC)-induced exacerbations in a murine smoke model affect DC populations Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 BCG effect in allergic response to ovalbumin in genetically selected strain of mice (IV-A) Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 Lipopolysaccharide (LPS) inhalation causes an increase in mucosal CD8+ve cells Source: Eur Respir J 2001; 18: Suppl. 33, 316s Year: 2001 Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004 Enhanced lung fibrosis in protein C inhibitor transgenic mice Source: Eur Respir J 2004; 24: Suppl. 48, 481s Year: 2004 Adaptive transfer of dendritic cells treated by 1,25-dihydroxy vitamin D3 prevent development of allergic airway inflammation in sensitized mice exposed to ovalbumin Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006 Allergen-induced inflammation and airway responsiveness in a mouse model of asthma: comparison between C57BL/6 and Th2-prone BALB/c mice Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003 A molecule derived from mycobacterium tuberculosis Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014